These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23762548)

  • 1. Evaluation of the significance of pretreatment liver biopsy and baseline mental health disorder diagnosis on hepatitis C treatment completion rates at a veterans affairs medical center.
    Kluck J; O'Flynn RM; Kaplan DE; Chang KM
    Hepat Res Treat; 2013; 2013():653976. PubMed ID: 23762548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCV eradication in veterans with underlying mental health disorders and substance use.
    Ifeachor AP; Houck KK; Schulte S; Ansara E; Johnson AJ; Carr TA; Liangpunsakul S
    J Am Pharm Assoc (2003); 2020; 60(6):1037-1043.e3. PubMed ID: 32948462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.
    Antúnez I; Aponte N; Fernández-Carbia A; Rodríguez-Perez F; Toro DH
    P R Health Sci J; 2004 Jun; 23(2 Suppl):57-60. PubMed ID: 16929588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of a Hepatitis C screening program at a large urban VA medical center.
    Groom H; Dieperink E; Nelson DB; Garrard J; Johnson JR; Ewing SL; Stockley H; Durfee J; Jonk Y; Willenbring ML; Ho SB
    J Clin Gastroenterol; 2008 Jan; 42(1):97-106. PubMed ID: 18097298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric comorbidity does not predict interferon treatment completion rates in hepatitis C seropositive veterans.
    Dollarhide AW; Loh C; Leckband SG; Endow-Eyer R; Robinson S; Meyer JM
    J Clin Gastroenterol; 2007 Mar; 41(3):322-8. PubMed ID: 17426475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System.
    Ioannou GN; Beste LA; Chang MF; Green PK; Lowy E; Tsui JI; Su F; Berry K
    Gastroenterology; 2016 Sep; 151(3):457-471.e5. PubMed ID: 27267053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders.
    Chainuvati S; Khalid SK; Kancir S; Shea M; Edwards J; Sernyak M; Wongcharatrawee S; Garcia-Tsao G
    J Viral Hepat; 2006 Apr; 13(4):235-41. PubMed ID: 16611189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment assessment and predictors of hepatitis C virus treatment in US veterans coinfected with HIV and hepatitis C virus.
    Backus LI; Boothroyd DB; Phillips BR; Mole LA
    J Viral Hepat; 2006 Dec; 13(12):799-810. PubMed ID: 17109679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of disease in U.S. veteran patients with hepatitis C.
    Nguyen HA; Miller AI; Dieperink E; Willenbring ML; Tetrick LL; Durfee JM; Ewing SL; Ho SB
    Am J Gastroenterol; 2002 Jul; 97(7):1813-20. PubMed ID: 12135041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.
    Hunt CM; Beste LA; Lowy E; Suzuki A; Moylan CA; Tillmann HL; Ioannou GN; Lim JK; Kelley MJ; Provenzale D
    World J Gastroenterol; 2016 May; 22(19):4732-40. PubMed ID: 27217704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing antiviral treatment through integrated hepatitis C care: a randomized multicenter trial.
    Groessl EJ; Sklar M; Cheung RC; Bräu N; Ho SB
    Contemp Clin Trials; 2013 Jul; 35(2):97-107. PubMed ID: 23669414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geographic Variation in Initiation of Evidence-based Psychotherapy Among Veterans With PTSD.
    Dufort VM; Bernardy N; Maguen S; Hoyt JE; Litt ER; Patterson OV; Leonard CE; Shiner B
    Mil Med; 2021 Aug; 186(9-10):e858-e866. PubMed ID: 33185663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How soon can a virological sustained response be determined after withdrawal of interferon therapy in chronic hepatitis C? Tokyo-Chiba Hepatitis Research Group.
    Shiratori Y; Kato N; Yoshida H; Imazeki F; Okano K; Yokosuka O; Omata M
    J Gastroenterol Hepatol; 1999 Jan; 14(1):79-84. PubMed ID: 10029282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained virological response: a milestone in the treatment of chronic hepatitis C.
    Morisco F; Granata R; Stroffolini T; Guarino M; Donnarumma L; Gaeta L; Loperto I; Gentile I; Auriemma F; Caporaso N
    World J Gastroenterol; 2013 May; 19(18):2793-8. PubMed ID: 23687416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C treatment completion rates in routine clinical care.
    Butt AA; McGinnis KA; Skanderson M; Justice AC
    Liver Int; 2010 Feb; 30(2):240-50. PubMed ID: 19889081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral therapy completion and response rates among hepatitis C patients with and without schizophrenia.
    Huckans M; Mitchell A; Ruimy S; Loftis J; Hauser P
    Schizophr Bull; 2010 Jan; 36(1):165-72. PubMed ID: 18562341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonresponse to interferon-α based treatment for chronic hepatitis C infection is associated with increased hazard of cirrhosis.
    Cozen ML; Ryan JC; Shen H; Lerrigo R; Yee RM; Sheen E; Wu R; Monto A
    PLoS One; 2013; 8(4):e61568. PubMed ID: 23637856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biopsy Specimens From Allograft Liver Contain Histologic Features of Hepatitis C Virus Infection After Virus Eradication.
    Whitcomb E; Choi WT; Jerome KR; Cook L; Landis C; Ahn J; Te HS; Esfeh J; Hanouneh IA; Rayhill SC; Gibson W; Plesec T; Koo J; Wang HL; Hart J; Pai RK; Westerhoff M
    Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1279-1285. PubMed ID: 28501538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Descriptive Analysis of a Community Clinic Providing Hepatitis C Treatment to Poor and Uninsured Patients.
    Sims OT; Melton PA; Ji S
    J Community Health; 2018 Aug; 43(4):725-730. PubMed ID: 29511988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.